Inizio, a commercialisation partner for health and life sciences, has made three senior appointments to drive its next phase ...

Inizio, a commercialization partner for health and life science companies, has today announced the appointment of Colin Stanley as ...

Sage Therapeutics has left its view of ... like its 2023 purchase of Reata Pharma and its rare disease therapy Skyclarys (omaveloxolone) for $7.3 billion and last year's $1.1 billion takeover ...

At a time when every news alert seems to deliver a seismic jolt about the world, these ads mostly touch on safe subjects we ...

Learn more about whether Biogen Inc. or Neurocrine Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The total shutdown of debate and conversation has eroded trust in science more than most people believed possible.

A Hungarian university may develop and start mass production of a miracle drug using the sweet woodworm, a Nobel Prize-winning herb.

Traditional Greek Medicine refers to ancient Greek practices that have aided in the healing of diseases and the maintenance ...

Community health centers are facing a potential federal freeze on their grants and funding following orders from Trump.

Glooko, Inc., a global integrated digital health company connecting patients, providers, biopharma, and medical device partners, and Innovation Zed, a pioneering developer of connected add-on devices ...

Biogen (NASDAQ:BIIB) shares experienced a change in market expectations as Cantor Fitzgerald revised the company's price target. The new target has been set at $206.00, a decrease from the previous ...